Brian I. Knapp

Durable Pharmacological Responses from the Peptide ShK-186, a Specific Kv1.3 Channel Inhibitor That Suppresses T Cell Mediators of Autoimmune Disease

Eric J. Tarcha, Victor Chi, Ernesto J. Muñoz‐Elías et al. · Journal of Pharmacology and Experimental Therapeutics · 2012 · 116 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +13

Design and Synthesis of Novel Dimeric Morphinan Ligands for κ and μ Opioid Receptors

John L. Neumeyer, Ao Zhang, Wennan Xiong et al. · Journal of Medicinal Chemistry · 2003 · 79 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Pharmacological Properties of Bivalent Ligands Containing Butorphan Linked to Nalbuphine, Naltrexone, and Naloxone at μ, δ, and κ Opioid Receptors

Xuemei Peng, Brian I. Knapp, Jean M. Bidlack et al. · Journal of Medicinal Chemistry · 2007 · 64 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

In Vitro Pharmacological Characterization of Buprenorphine, Samidorphan, and Combinations Being Developed as an Adjunctive Treatment of Major Depressive Disorder

Jean M. Bidlack, Brian I. Knapp, Daniel R. Deaver et al. · Journal of Pharmacology and Experimental Therapeutics · 2018 · 62 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Opioids activate brain analgesic circuits through cytochrome P450/epoxygenase signaling

Jennie Conroy, Cheng Fang, Jun Gu et al. · Nature Neuroscience · 2010 · 57 citations · Full text

Medicine, Neuroscience, Pharmacology +14